-
MDA Ambassador Guest Blog: How Adaptive Sports Changed My Life
Brayden is 17 years old and has been playing wheelchair basketball since he was 8. […]
-
Agamree becomes 1st approved DMD treatment in Canada
Health Canada has approved Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD) in patients ages […]
-
Catch Up on World Muscle Society 2025
Each year, the World Muscle Society (WMS) Annual Congress brings together the best minds in […]
-
Disability advocates let their voices be heard at symposium
A couple weeks ago, I co-emceed the Zero Project Asia Pacific Symposium 2025 with my […]
-
Building Protection: Vaccines and Dystrophinopathy
The PPMD team was recently joined by three clinical experts, Dr. Anne Pham-Huy (Pediatric Infectious […]
-
In Case You Missed It…
Quest Media is an innovative adaptive lifestyle platform from MDA. With the power of this […]
-
Exon-skipping therapy shows promise for DMD44
Delpacibart zotadirsen (del-zota), an investigational exon-skipping therapy from Avidity Biosciences, is demonstrating the potential to […]
-
Exon-skipping therapy shows promise for DMD44
Delpacibart zotadirsen (del-zota), an investigational exon-skipping therapy from Avidity Biosciences, is demonstrating the potential to […]
-
The how and why of living with limb-girdle muscular dystrophy
“He who has a why to live can bear almost any how.” — Friedrich Nietzsche I […]
-
Employer Matching Programs Double the Impact
Anybody who has made a monetary donation to support MDA’s mission knows well that their […]
